Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIOP) Change in Acquisitions & Divestments (2017 - 2019)

Historic Change in Acquisitions & Divestments for Fortress Biotech (FBIOP) over the last 3 years, with Q4 2019 value amounting to $5.0 million.

  • Fortress Biotech's Change in Acquisitions & Divestments fell 5000.0% to $5.0 million in Q4 2019 from the same period last year, while for Dec 2020 it was $5.0 million, marking a year-over-year decrease of 7788.0%. This contributed to the annual value of $22.6 million for FY2019, which is 6816.43% down from last year.
  • According to the latest figures from Q4 2019, Fortress Biotech's Change in Acquisitions & Divestments is $5.0 million, which was down 5000.0% from $5.0 million recorded in Q2 2019.
  • Fortress Biotech's 5-year Change in Acquisitions & Divestments high stood at $25.0 million for Q3 2018, and its period low was $8000.0 during Q2 2017.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $11.0 million (2018), whereas its average is $11.4 million.
  • In the last 5 years, Fortress Biotech's Change in Acquisitions & Divestments soared by 14992500.0% in 2018 and then tumbled by 5797.37% in 2019.
  • Over the past 3 years, Fortress Biotech's Change in Acquisitions & Divestments (Quarter) stood at $20.1 million in 2017, then crashed by 50.15% to $10.0 million in 2018, then tumbled by 50.0% to $5.0 million in 2019.
  • Its last three reported values are $5.0 million in Q4 2019, $5.0 million for Q2 2019, and $12.6 million during Q1 2019.